|
|
The Next Generation of Antibody Engineering Technologies and Antibody Therapeutics Development 2010 is a remarkable event that will focus on issues in the antibody industry. The meeting will converse about the most recent clinical developments relating to antibody therapeutics development, and will facilitate discussions between academia and industry about upcoming directions. The conference will enable attendees to gain knowledge about the successful implementation of antibody engineering. It will bestow valuable information on how to effectively apply biotherapeutics in the clinic to predict which new innovative therapies in order to achieve market successes. The Next Generation of Antibody Engineering Technologies and Antibody Therapeutics Development 2010 will feature keynote presentation, interactive panel discussion and therapeutic area case studies in antibody discovery, design, engineering areas ensuring the attendees maximum advantage of learning.
Visitor Profile
The targeted visitors at The Next Generation of Antibody Engineering Technologies and Antibody Therapeutics Development 2010 would include heads, engineers, VPs, directors, experts, and managers associated with
- Clinical Development & Research
- Antibody Development
- Pharmaceuticals
- Research & Development companies
- IP/ Patents
- Immunogenicity
- Solution Providers / Biotechs
- Technology and Equipment providers
- Antibody and Protein Engineering
- Preclinical Development & Research
- Academics and Professional Associations
- Governments and Regulators
- Business Development
- New Product Development
Organizer
InnoQube Ltd
